Dosage for Tresiba (insulin degludec) depends on the type of diabetes (type 1 or type 2) it is prescribed for and other factors. Your doctor may adjust your dosage over the course of your treatment.

As with other drugs, Tresiba (insulin degludec) can cause side effects, such as headache, upper respiratory infection, and injection site reaction. If side effects of Tresiba become difficult to ...

Novo Nordisk's long-acting insulin Tresiba is set to gain new hypoglycaemia prevention claims in Europe, giving it an advantage over Sanofi’s top-selling Lantus. Europe's CHMP committee has just ...

The approval covers all 27 European Union member states. Tresiba (insulin degludec) is a once-daily new-generation based insulin analogue with an ultra-long duration of action. Ryzodeg (insulin ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

were randomized 1:1 to technosphere inhaled insulin with long-acting basal insulin degludec (Tresiba) or usual care for 17 weeks. To enroll, patients needed to be on multiple daily insulin injections, ...

Sanjay Basu, Waymark, San Francisco, California. Kasia J. Lipska, Yale University. Insulin is considered an essential medicine for people with diabetes, but its price has doubled during the past ...

A new partnership had led to the development of the first-ever automated insulin delivery (AID) system that incorporates a 1-year glucose sensor. The twiist AID is approved for people aged 6 years ...

Consuming two cups of coffee daily could reduce your risk of insulin resistance by 23%, a new study in Korea has found. Insulin resistance is often a precursor to type 2 diabetes and occurs when ...